Description: Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.
Home Page: www.valeopharma.com
VPH Technical Analysis
16667 Hymus Boulevard
Kirkland,
QC
H9H 4R9
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Steven Saviuk CA | Vice Chairman & CEO |
| Mr. Luc Mainville M.B.A, M.B.A. | Sr. VP & CFO |
| Mr. Guy-Paul Allard | VP of Legal Affairs & Corp. Sec. |
| Mr. Frederic Dumais | Director of Communications & Investor Relations |
| Mr. Kyle Steiger | Sr. VP & Chief Commercial Officer |
| Mr. Jean Francois Fournier | Head of Ophthalmology Bus. Unit |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 71.6919 |
| Price-to-Sales TTM: | 2.4483 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 100 |